Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research2

FiltersClear all

Status

Completed2

Study type

Interventional2

Phase

Phase 22
Phase 312
Not applicable2

Investigator

Louis J Aronne2

Department

Medicine2

Condition

Carcinoma, Non-Small-Cell Lung11
Colitis, Ulcerative11
Prostatic Neoplasms11
Neoplasms9
Colorectal Neoplasms8

Intervention type

Drug2
Other2
Biological1

Sponsor type

Industry2

Start date

to

Has results posted1

Phase 2×Overweight×Clear all

Showing 1–2 of 2 studiesSort:

CompletedInterventional · Phase 2NCT05295875 ↗
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled and Parallel Group 48-Week Study to Evaluate the Efficacy and Safety of ALT-801 in the Treatment of Obesity (MOMENTUM Trial)

Show all 50

Show fewer

PI

Intervention: Drug: ALT-801 · Other: Placebo
Dates: Mar 2022 – Sep 2023
Sponsor: Altimmune, Inc.

Obesity/Overweight

CompletedInterventional · Phase 2NCT05616013 ↗

A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of Intravenous Bimagrumab, Alone or in Addition to Open Label Subcutaneous Semaglutide, to Investigate the Efficacy and Safety in Overweight or Obese Men and Women

Louis J AronnePI

Intervention: Biological: Bimagrumab · Drug: Semaglutide · Other: Placebo
Dates: Nov 2022 – May 2024· Results posted
Sponsor: Versanis Bio

ObesityObeseOverweight or Obesity